APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Veterinary Infectious Diseases Therapeutics

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Veterinary Infectious Diseases Therapeutics Market Analysis and Forecast 2026-2032

Report ID 174046130222 December 2025196 pages

Choose your research edition.

Industry ResearchVeterinary Infectious Diseases Therapeutics Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Veterinary Infectious Diseases Therapeutics Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Veterinary Infectious Diseases Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Veterinary Infectious Diseases Therapeutics Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Veterinary Infectious Diseases Therapeutics Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Veterinary Infectious Diseases Therapeutics market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Veterinary Infectious Diseases Therapeutics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Veterinary Infectious Diseases Therapeutics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Veterinary Infectious Diseases Therapeutics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Veterinary Infectious Diseases Therapeutics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Veterinary Infectious Diseases Therapeutics include Sanofi, Merck, Virbac, Pfizer Animal Health, Novartis Animal Health, Elanco Animal Health, Elanco Animal Health, Dechra Animal Health and Ceva Sante Animale, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Veterinary Infectious Diseases Therapeutics, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Veterinary Infectious Diseases Therapeutics, also provides the sales of main regions and countries. Of the upcoming market potential for Veterinary Infectious Diseases Therapeutics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Veterinary Infectious Diseases Therapeutics sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Veterinary Infectious Diseases Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Veterinary Infectious Diseases Therapeutics sales, projected growth trends, production technology, application and end-user industry.

Veterinary Infectious Diseases Therapeutics Segment by Company

Sanofi

Merck

Virbac

Pfizer Animal Health

Novartis Animal Health

Elanco Animal Health

Elanco Animal Health

Dechra Animal Health

Ceva Sante Animale

Boehringer Ingelheim Vetmedica

Veterinary Infectious Diseases Therapeutics Segment by Type

Amebicides

Anthelmintics

Antifungal

Antibiotics

Antiviral

Veterinary Infectious Diseases Therapeutics Segment by Application

Swine

Cow

Cat

Horse

Chicken

Dog

Other

Veterinary Infectious Diseases Therapeutics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Infectious Diseases Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Veterinary Infectious Diseases Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Infectious Diseases Therapeutics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Veterinary Infectious Diseases Therapeutics in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Veterinary Infectious Diseases Therapeutics manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Veterinary Infectious Diseases Therapeutics sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Veterinary Infectious Diseases Therapeutics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Amebicides Major Manufacturers Table 3. Anthelmintics Major Manufacturers Table 4. Antifungal Major Manufacturers Table 5. Antibiotics Major Manufacturers Table 6. Antiviral Major Manufacturers Table 7. Global Veterinary Infectious Diseases Therapeutics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Swine Major Manufacturers Table 9. Cow Major Manufacturers Table 10. Cat Major Manufacturers Table 11. Horse Major Manufacturers Table 12. Chicken Major Manufacturers Table 13. Dog Major Manufacturers Table 14. Other Major Manufacturers Table 15. Veterinary Infectious Diseases Therapeutics Industry Trends Table 16. Veterinary Infectious Diseases Therapeutics Industry Drivers Table 17. Veterinary Infectious Diseases Therapeutics Industry Opportunities and Challenges Table 18. Veterinary Infectious Diseases Therapeutics Industry Restraints Table 19. Global Veterinary Infectious Diseases Therapeutics Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global Veterinary Infectious Diseases Therapeutics Revenue by Region (2021-2026) & (US$ Million) Table 21. Global Veterinary Infectious Diseases Therapeutics Revenue by Region (2027-2032) & (US$ Million) Table 22. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Region (2021-2026) Table 23. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Region (2027-2032) Table 24. Global Veterinary Infectious Diseases Therapeutics Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (kg) Table 25. Global Veterinary Infectious Diseases Therapeutics Sales by Region (2021-2026) & (kg) Table 26. Global Veterinary Infectious Diseases Therapeutics Sales by Region (2027-2032) & (kg) Table 27. Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Region (2021-2026) Table 28. Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Region (2027-2032) Table 29. Global Veterinary Infectious Diseases Therapeutics Revenue by Manufacturers (US$ Million) & (2021-2026) Table 30. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Manufacturers (2021-2026) Table 31. Global Veterinary Infectious Diseases Therapeutics Sales by Manufacturers (US$ Million) & (2021-2026) Table 32. Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Manufacturers (2021-2026) Table 33. Global Veterinary Infectious Diseases Therapeutics Sales Price (US$/kg) of Manufacturers (2021-2026) Table 34. Global Veterinary Infectious Diseases Therapeutics Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 35. Global Veterinary Infectious Diseases Therapeutics Key Manufacturers Manufacturing Sites & Headquarters Table 36. Global Veterinary Infectious Diseases Therapeutics Manufacturers, Product Type & Application Table 37. Global Veterinary Infectious Diseases Therapeutics Manufacturers' Establishment Date Table 38. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 39. Global Veterinary Infectious Diseases Therapeutics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Veterinary Infectious Diseases Therapeutics Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Veterinary Infectious Diseases Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 42. Global Veterinary Infectious Diseases Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 43. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Type (2021-2026) Table 44. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Type (2027-2032) Table 45. Global Veterinary Infectious Diseases Therapeutics Sales by Type 2021 VS 2025 VS 2032 (kg) Table 46. Global Veterinary Infectious Diseases Therapeutics Sales by Type (2021-2026) & (kg) Table 47. Global Veterinary Infectious Diseases Therapeutics Sales by Type (2027-2032) & (kg) Table 48. Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2021-2026) Table 49. Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2027-2032) Table 50. Global Veterinary Infectious Diseases Therapeutics Price by Type (2021-2026) & (US$/kg) Table 51. Global Veterinary Infectious Diseases Therapeutics Price by Type (2027-2032) & (US$/kg) Table 52. Global Veterinary Infectious Diseases Therapeutics Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 53. Global Veterinary Infectious Diseases Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 54. Global Veterinary Infectious Diseases Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 55. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Application (2021-2026) Table 56. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Application (2027-2032) Table 57. Global Veterinary Infectious Diseases Therapeutics Sales by Application 2021 VS 2025 VS 2032 (kg) Table 58. Global Veterinary Infectious Diseases Therapeutics Sales by Application (2021-2026) & (kg) Table 59. Global Veterinary Infectious Diseases Therapeutics Sales by Application (2027-2032) & (kg) Table 60. Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2021-2026) Table 61. Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2027-2032) Table 62. Global Veterinary Infectious Diseases Therapeutics Price by Application (2021-2026) & (US$/kg) Table 63. Global Veterinary Infectious Diseases Therapeutics Price by Application (2027-2032) & (US$/kg) Table 64. Sanofi Company Information Table 65. Sanofi Business Overview Table 66. Sanofi Veterinary Infectious Diseases Therapeutics Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 67. Sanofi Veterinary Infectious Diseases Therapeutics Product Portfolio Table 68. Sanofi Recent Development Table 69. Merck Company Information Table 70. Merck Business Overview Table 71. Merck Veterinary Infectious Diseases Therapeutics Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 72. Merck Veterinary Infectious Diseases Therapeutics Product Portfolio Table 73. Merck Recent Development Table 74. Virbac Company Information Table 75. Virbac Business Overview Table 76. Virbac Veterinary Infectious Diseases Therapeutics Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 77. Virbac Veterinary Infectious Diseases Therapeutics Product Portfolio Table 78. Virbac Recent Development Table 79. Pfizer Animal Health Company Information Table 80. Pfizer Animal Health Business Overview Table 81. Pfizer Animal Health Veterinary Infectious Diseases Therapeutics Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 82. Pfizer Animal Health Veterinary Infectious Diseases Therapeutics Product Portfolio Table 83. Pfizer Animal Health Recent Development Table 84. Novartis Animal Health Company Information Table 85. Novartis Animal Health Business Overview Table 86. Novartis Animal Health Veterinary Infectious Diseases Therapeutics Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 87. Novartis Animal Health Veterinary Infectious Diseases Therapeutics Product Portfolio Table 88. Novartis Animal Health Recent Development Table 89. Elanco Animal Health Company Information Table 90. Elanco Animal Health Business Overview Table 91. Elanco Animal Health Veterinary Infectious Diseases Therapeutics Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 92. Elanco Animal Health Veterinary Infectious Diseases Therapeutics Product Portfolio Table 93. Elanco Animal Health Recent Development Table 94. Elanco Animal Health Company Information Table 95. Elanco Animal Health Business Overview Table 96. Elanco Animal Health Veterinary Infectious Diseases Therapeutics Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 97. Elanco Animal Health Veterinary Infectious Diseases Therapeutics Product Portfolio Table 98. Elanco Animal Health Recent Development Table 99. Dechra Animal Health Company Information Table 100. Dechra Animal Health Business Overview Table 101. Dechra Animal Health Veterinary Infectious Diseases Therapeutics Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 102. Dechra Animal Health Veterinary Infectious Diseases Therapeutics Product Portfolio Table 103. Dechra Animal Health Recent Development Table 104. Ceva Sante Animale Company Information Table 105. Ceva Sante Animale Business Overview Table 106. Ceva Sante Animale Veterinary Infectious Diseases Therapeutics Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 107. Ceva Sante Animale Veterinary Infectious Diseases Therapeutics Product Portfolio Table 108. Ceva Sante Animale Recent Development Table 109. Boehringer Ingelheim Vetmedica Company Information Table 110. Boehringer Ingelheim Vetmedica Business Overview Table 111. Boehringer Ingelheim Vetmedica Veterinary Infectious Diseases Therapeutics Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 112. Boehringer Ingelheim Vetmedica Veterinary Infectious Diseases Therapeutics Product Portfolio Table 113. Boehringer Ingelheim Vetmedica Recent Development Table 114. North America Veterinary Infectious Diseases Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 115. North America Veterinary Infectious Diseases Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 116. North America Veterinary Infectious Diseases Therapeutics Sales by Type (2021-2026) & (kg) Table 117. North America Veterinary Infectious Diseases Therapeutics Sales by Type (2027-2032) & (kg) Table 118. North America Veterinary Infectious Diseases Therapeutics Sales Price by Type (2021-2026) & (US$/kg) Table 119. North America Veterinary Infectious Diseases Therapeutics Sales Price by Type (2027-2032) & (US$/kg) Table 120. North America Veterinary Infectious Diseases Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 121. North America Veterinary Infectious Diseases Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 122. North America Veterinary Infectious Diseases Therapeutics Sales by Application (2021-2026) & (kg) Table 123. North America Veterinary Infectious Diseases Therapeutics Sales by Application (2027-2032) & (kg) Table 124. North America Veterinary Infectious Diseases Therapeutics Sales Price by Application (2021-2026) & (US$/kg) Table 125. North America Veterinary Infectious Diseases Therapeutics Sales Price by Application (2027-2032) & (US$/kg) Table 126. North America Veterinary Infectious Diseases Therapeutics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 127. North America Veterinary Infectious Diseases Therapeutics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 128. North America Veterinary Infectious Diseases Therapeutics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 129. North America Veterinary Infectious Diseases Therapeutics Sales by Country (2021 VS 2025 VS 2032) & (kg) Table 130. North America Veterinary Infectious Diseases Therapeutics Sales by Country (2021-2026) & (kg) Table 131. North America Veterinary Infectious Diseases Therapeutics Sales by Country (2027-2032) & (kg) Table 132. North America Veterinary Infectious Diseases Therapeutics Sales Price by Country (2021-2026) & (US$/kg) Table 133. North America Veterinary Infectious Diseases Therapeutics Sales Price by Country (2027-2032) & (US$/kg) Table 134. United States Veterinary Infectious Diseases Therapeutics Revenue (2021-2032) & (US$ Million) Table 135. Canada Veterinary Infectious Diseases Therapeutics Revenue (2021-2032) & (US$ Million) Table 136. Mexico Veterinary Infectious Diseases Therapeutics Revenue (2021-2032) & (US$ Million) Table 137. Europe Veterinary Infectious Diseases Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 138. Europe Veterinary Infectious Diseases Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 139. Europe Veterinary Infectious Diseases Therapeutics Sales by Type (2021-2026) & (kg) Table 140. Europe Veterinary Infectious Diseases Therapeutics Sales by Type (2027-2032) & (kg) Table 141. Europe Veterinary Infectious Diseases Therapeutics Sales Price by Type (2021-2026) & (US$/kg) Table 142. Europe Veterinary Infectious Diseases Therapeutics Sales Price by Type (2027-2032) & (US$/kg) Table 143. Europe Veterinary Infectious Diseases Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 144. Europe Veterinary Infectious Diseases Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 145. Europe Veterinary Infectious Diseases Therapeutics Sales by Application (2021-2026) & (kg) Table 146. Europe Veterinary Infectious Diseases Therapeutics Sales by Application (2027-2032) & (kg) Table 147. Europe Veterinary Infectious Diseases Therapeutics Sales Price by Application (2021-2026) & (US$/kg) Table 148. Europe Veterinary Infectious Diseases Therapeutics Sales Price by Application (2027-2032) & (US$/kg) Table 149. Europe Veterinary Infectious Diseases Therapeutics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 150. Europe Veterinary Infectious Diseases Therapeutics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 151. Europe Veterinary Infectious Diseases Therapeutics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 152. Europe Veterinary Infectious Diseases Therapeutics Sales by Country (2021 VS 2025 VS 2032) & (kg) Table 153. Europe Veterinary Infectious Diseases Therapeutics Sales by Country (2021-2026) & (kg) Table 154. Europe Veterinary Infectious Diseases Therapeutics Sales by Country (2027-2032) & (kg) Table 155. Europe Veterinary Infectious Diseases Therapeutics Sales Price by Country (2021-2026) & (US$/kg) Table 156. Europe Veterinary Infectious Diseases Therapeutics Sales Price by Country (2027-2032) & (US$/kg) Table 157. Germany Veterinary Infectious Diseases Therapeutics Revenue (2021-2032) & (US$ Million) Table 158. France Veterinary Infectious Diseases Therapeutics Revenue (2021-2032) & (US$ Million) Table 159. U.K. Veterinary Infectious Diseases Therapeutics Revenue (2021-2032) & (US$ Million) Table 160. Italy Veterinary Infectious Diseases Therapeutics Revenue (2021-2032) & (US$ Million) Table 161. Russia Veterinary Infectious Diseases Therapeutics Revenue (2021-2032) & (US$ Million) Table 162. Spain Veterinary Infectious Diseases Therapeutics Revenue (2021-2032) & (US$ Million) Table 163. Netherlands Veterinary Infectious Diseases Therapeutics Revenue (2021-2032) & (US$ Million) Table 164. Switzerland Veterinary Infectious Diseases Therapeutics Revenue (2021-2032) & (US$ Million) Table 165. Sweden Veterinary Infectious Diseases Therapeutics Revenue (2021-2032) & (US$ Million) Table 166. Poland Veterinary Infectious Diseases Therapeutics Revenue (2021-2032) & (US$ Million) Table 167. China Veterinary Infectious Diseases Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 168. China Veterinary Infectious Diseases Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 169. China Veterinary Infectious Diseases Therapeutics Sales by Type (2021-2026) & (kg) Table 170. China Veterinary Infectious Diseases Therapeutics Sales by Type (2027-2032) & (kg) Table 171. China Veterinary Infectious Diseases Therapeutics Sales Price by Type (2021-2026) & (US$/kg) Table 172. China Veterinary Infectious Diseases Therapeutics Sales Price by Type (2027-2032) & (US$/kg) Table 173. China Veterinary Infectious Diseases Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 174. China Veterinary Infectious Diseases Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 175. China Veterinary Infectious Diseases Therapeutics Sales by Application (2021-2026) & (kg) Table 176. China Veterinary Infectious Diseases Therapeutics Sales by Application (2027-2032) & (kg) Table 177. China Veterinary Infectious Diseases Therapeutics Sales Price by Application (2021-2026) & (US$/kg) Table 178. China Veterinary Infectious Diseases Therapeutics Sales Price by Application (2027-2032) & (US$/kg) Table 179. Asia Veterinary Infectious Diseases Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 180. Asia Veterinary Infectious Diseases Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 181. Asia Veterinary Infectious Diseases Therapeutics Sales by Type (2021-2026) & (kg) Table 182. Asia Veterinary Infectious Diseases Therapeutics Sales by Type (2027-2032) & (kg) Table 183. Asia Veterinary Infectious Diseases Therapeutics Sales Price by Type (2021-2026) & (US$/kg) Table 184. Asia Veterinary Infectious Diseases Therapeutics Sales Price by Type (2027-2032) & (US$/kg) Table 185. Asia Veterinary Infectious Diseases Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 186. Asia Veterinary Infectious Diseases Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 187. Asia Veterinary Infectious Diseases Therapeutics Sales by Application (2021-2026) & (kg) Table 188. Asia Veterinary Infectious Diseases Therapeutics Sales by Application (2027-2032) & (kg) Table 189. Asia Veterinary Infectious Diseases Therapeutics Sales Price by Application (2021-2026) & (US$/kg) Table 190. Asia Veterinary Infectious Diseases Therapeutics Sales Price by Application (2027-2032) & (US$/kg) Table 191. Asia Veterinary Infectious Diseases Therapeutics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 192. Asia Veterinary Infectious Diseases Therapeutics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 193. Asia Veterinary Infectious Diseases Therapeutics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 194. Asia Veterinary Infectious Diseases Therapeutics Sales by Country (2021 VS 2025 VS 2032) & (kg) Table 195. Asia Veterinary Infectious Diseases Therapeutics Sales by Country (2021-2026) & (kg) Table 196. Asia Veterinary Infectious Diseases Therapeutics Sales by Country (2027-2032) & (kg) Table 197. Asia Veterinary Infectious Diseases Therapeutics Sales Price by Country (2021-2026) & (US$/kg) Table 198. Asia Veterinary Infectious Diseases Therapeutics Sales Price by Country (2027-2032) & (US$/kg) Table 199. Japan Veterinary Infectious Diseases Therapeutics Revenue (2021-2032) & (US$ Million) Table 200. South Korea Veterinary Infectious Diseases Therapeutics Revenue (2021-2032) & (US$ Million) Table 201. India Veterinary Infectious Diseases Therapeutics Revenue (2021-2032) & (US$ Million) Table 202. Australia Veterinary Infectious Diseases Therapeutics Revenue (2021-2032) & (US$ Million) Table 203. Taiwan Veterinary Infectious Diseases Therapeutics Revenue (2021-2032) & (US$ Million) Table 204. Southeast Asia Veterinary Infectious Diseases Therapeutics Revenue (2021-2032) & (US$ Million) Table 205. SAMEA Veterinary Infectious Diseases Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 206. SAMEA Veterinary Infectious Diseases Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 207. SAMEA Veterinary Infectious Diseases Therapeutics Sales by Type (2021-2026) & (kg) Table 208. SAMEA Veterinary Infectious Diseases Therapeutics Sales by Type (2027-2032) & (kg) Table 209. SAMEA Veterinary Infectious Diseases Therapeutics Sales Price by Type (2021-2026) & (US$/kg) Table 210. SAMEA Veterinary Infectious Diseases Therapeutics Sales Price by Type (2027-2032) & (US$/kg) Table 211. SAMEA Veterinary Infectious Diseases Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 212. SAMEA Veterinary Infectious Diseases Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 213. SAMEA Veterinary Infectious Diseases Therapeutics Sales by Application (2021-2026) & (kg) Table 214. SAMEA Veterinary Infectious Diseases Therapeutics Sales by Application (2027-2032) & (kg) Table 215. SAMEA Veterinary Infectious Diseases Therapeutics Sales Price by Application (2021-2026) & (US$/kg) Table 216. SAMEA Veterinary Infectious Diseases Therapeutics Sales Price by Application (2027-2032) & (US$/kg) Table 217. SAMEA Veterinary Infectious Diseases Therapeutics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 218. SAMEA Veterinary Infectious Diseases Therapeutics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 219. SAMEA Veterinary Infectious Diseases Therapeutics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 220. SAMEA Veterinary Infectious Diseases Therapeutics Sales by Country (2021 VS 2025 VS 2032) & (kg) Table 221. SAMEA Veterinary Infectious Diseases Therapeutics Sales by Country (2021-2026) & (kg) Table 222. SAMEA Veterinary Infectious Diseases Therapeutics Sales by Country (2027-2032) & (kg) Table 223. SAMEA Veterinary Infectious Diseases Therapeutics Sales Price by Country (2021-2026) & (US$/kg) Table 224. SAMEA Veterinary Infectious Diseases Therapeutics Sales Price by Country (2027-2032) & (US$/kg) Table 225. Brazil Veterinary Infectious Diseases Therapeutics Revenue (2021-2032) & (US$ Million) Table 226. Argentina Veterinary Infectious Diseases Therapeutics Revenue (2021-2032) & (US$ Million) Table 227. Chile Veterinary Infectious Diseases Therapeutics Revenue (2021-2032) & (US$ Million) Table 228. Colombia Veterinary Infectious Diseases Therapeutics Revenue (2021-2032) & (US$ Million) Table 229. Peru Veterinary Infectious Diseases Therapeutics Revenue (2021-2032) & (US$ Million) Table 230. Saudi Arabia Veterinary Infectious Diseases Therapeutics Revenue (2021-2032) & (US$ Million) Table 231. Israel Veterinary Infectious Diseases Therapeutics Revenue (2021-2032) & (US$ Million) Table 232. UAE Veterinary Infectious Diseases Therapeutics Revenue (2021-2032) & (US$ Million) Table 233. Turkey Veterinary Infectious Diseases Therapeutics Revenue (2021-2032) & (US$ Million) Table 234. Iran Veterinary Infectious Diseases Therapeutics Revenue (2021-2032) & (US$ Million) Table 235. Egypt Veterinary Infectious Diseases Therapeutics Revenue (2021-2032) & (US$ Million) Table 236. Key Raw Materials Table 237. Raw Materials Key Suppliers Table 238. Veterinary Infectious Diseases Therapeutics Distributors List Table 239. Veterinary Infectious Diseases Therapeutics Customers List Table 240. Research Programs/Design for This Report Table 241. Authors List of This Report Table 242. Secondary Sources Table 243. Primary Sources List of Figures Figure 1. Veterinary Infectious Diseases Therapeutics Image Figure 2. Global Veterinary Infectious Diseases Therapeutics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Veterinary Infectious Diseases Therapeutics Market Size Share 2021 VS 2025 VS 2032 Figure 4. Amebicides Image Figure 5. Anthelmintics Image Figure 6. Antifungal Image Figure 7. Antibiotics Image Figure 8. Antiviral Image Figure 9. Global Veterinary Infectious Diseases Therapeutics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Veterinary Infectious Diseases Therapeutics Market Size Share 2021 VS 2025 VS 2032 Figure 11. Swine Image Figure 12. Cow Image Figure 13. Cat Image Figure 14. Horse Image Figure 15. Chicken Image Figure 16. Dog Image Figure 17. Other Image Figure 18. Global Veterinary Infectious Diseases Therapeutics Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 19. Global Veterinary Infectious Diseases Therapeutics Revenue (2021-2032) & (US$ Million) Figure 20. Global Veterinary Infectious Diseases Therapeutics Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Region: 2025 Versus 2032 Figure 22. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Region (2021-2032) Figure 23. Global Veterinary Infectious Diseases Therapeutics Sales (2021-2032) & (kg) Figure 24. Global Veterinary Infectious Diseases Therapeutics Sales by Region: 2021 VS 2025 VS 2032 (kg) Figure 25. Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Region (2021-2032) Figure 26. US & Canada & Mexico Veterinary Infectious Diseases Therapeutics Sales YoY (2021-2032) & (kg) Figure 27. Europe Veterinary Infectious Diseases Therapeutics Sales YoY (2021-2032) & (kg) Figure 28. China Veterinary Infectious Diseases Therapeutics Sales YoY (2021-2032) & (kg) Figure 29. Asia (Excluding China) Veterinary Infectious Diseases Therapeutics Sales YoY (2021-2032) & (kg) Figure 30. South America, Middle East and Africa Veterinary Infectious Diseases Therapeutics Sales YoY (2021-2032) & (kg) Figure 31. Global Veterinary Infectious Diseases Therapeutics Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 32. Global Veterinary Infectious Diseases Therapeutics Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 33. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 34. Global Veterinary Infectious Diseases Therapeutics Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 36. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Type (2021-2032) Figure 37. Global Veterinary Infectious Diseases Therapeutics Sales by Type (2021 VS 2025 VS 2032) & (kg) Figure 38. Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 39. Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2021-2032) Figure 40. Global Veterinary Infectious Diseases Therapeutics Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 41. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 42. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Application (2021-2032) Figure 43. Global Veterinary Infectious Diseases Therapeutics Sales by Application (2021 VS 2025 VS 2032) & (kg) Figure 44. Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 45. Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2021-2032) Figure 46. North America Veterinary Infectious Diseases Therapeutics Revenue Share by Type (2021-2032) Figure 47. North America Veterinary Infectious Diseases Therapeutics Sales Share by Type (2021-2032) Figure 48. North America Veterinary Infectious Diseases Therapeutics Revenue Share by Application (2021-2032) Figure 49. North America Veterinary Infectious Diseases Therapeutics Sales Share by Application (2021-2032) Figure 50. North America Veterinary Infectious Diseases Therapeutics Revenue Share by Country (2021-2032) Figure 51. North America Veterinary Infectious Diseases Therapeutics Sales Share by Country (2021-2032) Figure 52. Europe Veterinary Infectious Diseases Therapeutics Revenue Share by Type (2021-2032) Figure 53. Europe Veterinary Infectious Diseases Therapeutics Sales Share by Type (2021-2032) Figure 54. Europe Veterinary Infectious Diseases Therapeutics Revenue Share by Application (2021-2032) Figure 55. Europe Veterinary Infectious Diseases Therapeutics Sales Share by Application (2021-2032) Figure 56. Europe Veterinary Infectious Diseases Therapeutics Revenue Share by Country (2021-2032) Figure 57. Europe Veterinary Infectious Diseases Therapeutics Sales Share by Country (2021-2032) Figure 58. China Veterinary Infectious Diseases Therapeutics Revenue Share by Type (2021-2032) Figure 59. China Veterinary Infectious Diseases Therapeutics Sales Share by Type (2021-2032) Figure 60. China Veterinary Infectious Diseases Therapeutics Revenue Share by Application (2021-2032) Figure 61. China Veterinary Infectious Diseases Therapeutics Sales Share by Application (2021-2032) Figure 62. Asia Veterinary Infectious Diseases Therapeutics Revenue Share by Type (2021-2032) Figure 63. Asia Veterinary Infectious Diseases Therapeutics Sales Share by Type (2021-2032) Figure 64. Asia Veterinary Infectious Diseases Therapeutics Revenue Share by Application (2021-2032) Figure 65. Asia Veterinary Infectious Diseases Therapeutics Sales Share by Application (2021-2032) Figure 66. Asia Veterinary Infectious Diseases Therapeutics Revenue Share by Country (2021-2032) Figure 67. Asia Veterinary Infectious Diseases Therapeutics Sales Share by Country (2021-2032) Figure 68. SAMEA Veterinary Infectious Diseases Therapeutics Revenue Share by Type (2021-2032) Figure 69. SAMEA Veterinary Infectious Diseases Therapeutics Sales Share by Type (2021-2032) Figure 70. SAMEA Veterinary Infectious Diseases Therapeutics Revenue Share by Application (2021-2032) Figure 71. SAMEA Veterinary Infectious Diseases Therapeutics Sales Share by Application (2021-2032) Figure 72. SAMEA Veterinary Infectious Diseases Therapeutics Revenue Share by Country (2021-2032) Figure 73. SAMEA Veterinary Infectious Diseases Therapeutics Sales Share by Country (2021-2032) Figure 74. Veterinary Infectious Diseases Therapeutics Value Chain Figure 75. Manufacturing Cost Structure Figure 76. Veterinary Infectious Diseases Therapeutics Production Mode & Process Figure 77. Direct Comparison with Distribution Share Figure 78. Distributors Profiles Figure 79. Years Considered Figure 80. Research Process Figure 81. Key Executives Interviewed

Scope & coverage.

Types
  • Amebicides
  • Anthelmintics
  • Antifungal
  • Antibiotics
  • Antiviral
Applications
  • Swine
  • Cow
  • Cat
  • Horse
  • Chicken
  • Dog
  • Other
Companies covered
  • Sanofi
  • Merck
  • Virbac
  • Pfizer Animal Health
  • Novartis Animal Health
  • Elanco Animal Health
  • Elanco Animal Health
  • Dechra Animal Health
  • Ceva Sante Animale
  • Boehringer Ingelheim Vetmedica

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Veterinary Infectious Diseases Therapeutics Market by Type
  3. 1.2.1 Global Veterinary Infectious Diseases Therapeutics Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Amebicides
  5. 1.2.3 Anthelmintics
  6. 1.2.4 Antifungal
  7. 1.2.5 Antibiotics
  8. 1.2.6 Antiviral
  9. 1.3 Veterinary Infectious Diseases Therapeutics Market by Application
  10. 1.3.1 Global Veterinary Infectious Diseases Therapeutics Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Swine
  12. 1.3.3 Cow
  13. 1.3.4 Cat
  14. 1.3.5 Horse
  15. 1.3.6 Chicken
  16. 1.3.7 Dog
  17. 1.3.8 Other
  18. 1.4 Assumptions and Limitations
  19. 1.5 Study Goals and Objectives
2 Veterinary Infectious Diseases Therapeutics Market Dynamics
  1. 2.1 Veterinary Infectious Diseases Therapeutics Industry Trends
  2. 2.2 Veterinary Infectious Diseases Therapeutics Industry Drivers
  3. 2.3 Veterinary Infectious Diseases Therapeutics Industry Opportunities and Challenges
  4. 2.4 Veterinary Infectious Diseases Therapeutics Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Veterinary Infectious Diseases Therapeutics Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Veterinary Infectious Diseases Therapeutics Revenue by Region
  3. 3.2.1 Global Veterinary Infectious Diseases Therapeutics Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Veterinary Infectious Diseases Therapeutics Revenue by Region (2021-2026)
  5. 3.2.3 Global Veterinary Infectious Diseases Therapeutics Revenue by Region (2027-2032)
  6. 3.2.4 Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Veterinary Infectious Diseases Therapeutics Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Veterinary Infectious Diseases Therapeutics Sales by Region
  9. 3.4.1 Global Veterinary Infectious Diseases Therapeutics Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Veterinary Infectious Diseases Therapeutics Sales by Region (2021-2026)
  11. 3.4.3 Global Veterinary Infectious Diseases Therapeutics Sales by Region (2027-2032)
  12. 3.4.4 Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Veterinary Infectious Diseases Therapeutics Revenue by Manufacturers
  2. 4.1.1 Global Veterinary Infectious Diseases Therapeutics Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Veterinary Infectious Diseases Therapeutics Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Veterinary Infectious Diseases Therapeutics Sales by Manufacturers
  6. 4.2.1 Global Veterinary Infectious Diseases Therapeutics Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Veterinary Infectious Diseases Therapeutics Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Veterinary Infectious Diseases Therapeutics Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Veterinary Infectious Diseases Therapeutics Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Veterinary Infectious Diseases Therapeutics Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Veterinary Infectious Diseases Therapeutics Manufacturers, Product Type & Application
  13. 4.7 Global Veterinary Infectious Diseases Therapeutics Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Veterinary Infectious Diseases Therapeutics Market CR5 and HHI
  16. 4.8.2 2025 Veterinary Infectious Diseases Therapeutics Tier 1, Tier 2, and Tier 3
5 Veterinary Infectious Diseases Therapeutics Market by Type
  1. 5.1 Global Veterinary Infectious Diseases Therapeutics Revenue by Type
  2. 5.1.1 Global Veterinary Infectious Diseases Therapeutics Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Veterinary Infectious Diseases Therapeutics Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Veterinary Infectious Diseases Therapeutics Sales by Type
  6. 5.2.1 Global Veterinary Infectious Diseases Therapeutics Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Veterinary Infectious Diseases Therapeutics Sales by Type (2021-2032) & (kg)
  8. 5.2.3 Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2021-2032)
  9. 5.3 Global Veterinary Infectious Diseases Therapeutics Price by Type
6 Veterinary Infectious Diseases Therapeutics Market by Application
  1. 6.1 Global Veterinary Infectious Diseases Therapeutics Revenue by Application
  2. 6.1.1 Global Veterinary Infectious Diseases Therapeutics Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Veterinary Infectious Diseases Therapeutics Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Veterinary Infectious Diseases Therapeutics Sales by Application
  6. 6.2.1 Global Veterinary Infectious Diseases Therapeutics Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Veterinary Infectious Diseases Therapeutics Sales by Application (2021-2032) & (kg)
  8. 6.2.3 Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2021-2032)
  9. 6.3 Global Veterinary Infectious Diseases Therapeutics Price by Application
7 Company Profiles
  1. 7.1 Sanofi
  2. 7.1.1 Sanofi Company Information
  3. 7.1.2 Sanofi Business Overview
  4. 7.1.3 Sanofi Veterinary Infectious Diseases Therapeutics Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Sanofi Veterinary Infectious Diseases Therapeutics Product Portfolio
  6. 7.1.5 Sanofi Recent Developments
  7. 7.2 Merck
  8. 7.2.1 Merck Company Information
  9. 7.2.2 Merck Business Overview
  10. 7.2.3 Merck Veterinary Infectious Diseases Therapeutics Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Merck Veterinary Infectious Diseases Therapeutics Product Portfolio
  12. 7.2.5 Merck Recent Developments
  13. 7.3 Virbac
  14. 7.3.1 Virbac Company Information
  15. 7.3.2 Virbac Business Overview
  16. 7.3.3 Virbac Veterinary Infectious Diseases Therapeutics Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Virbac Veterinary Infectious Diseases Therapeutics Product Portfolio
  18. 7.3.5 Virbac Recent Developments
  19. 7.4 Pfizer Animal Health
  20. 7.4.1 Pfizer Animal Health Company Information
  21. 7.4.2 Pfizer Animal Health Business Overview
  22. 7.4.3 Pfizer Animal Health Veterinary Infectious Diseases Therapeutics Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Pfizer Animal Health Veterinary Infectious Diseases Therapeutics Product Portfolio
  24. 7.4.5 Pfizer Animal Health Recent Developments
  25. 7.5 Novartis Animal Health
  26. 7.5.1 Novartis Animal Health Company Information
  27. 7.5.2 Novartis Animal Health Business Overview
  28. 7.5.3 Novartis Animal Health Veterinary Infectious Diseases Therapeutics Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Novartis Animal Health Veterinary Infectious Diseases Therapeutics Product Portfolio
  30. 7.5.5 Novartis Animal Health Recent Developments
  31. 7.6 Elanco Animal Health
  32. 7.6.1 Elanco Animal Health Company Information
  33. 7.6.2 Elanco Animal Health Business Overview
  34. 7.6.3 Elanco Animal Health Veterinary Infectious Diseases Therapeutics Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Elanco Animal Health Veterinary Infectious Diseases Therapeutics Product Portfolio
  36. 7.6.5 Elanco Animal Health Recent Developments
  37. 7.7 Elanco Animal Health
  38. 7.7.1 Elanco Animal Health Company Information
  39. 7.7.2 Elanco Animal Health Business Overview
  40. 7.7.3 Elanco Animal Health Veterinary Infectious Diseases Therapeutics Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Elanco Animal Health Veterinary Infectious Diseases Therapeutics Product Portfolio
  42. 7.7.5 Elanco Animal Health Recent Developments
  43. 7.8 Dechra Animal Health
  44. 7.8.1 Dechra Animal Health Company Information
  45. 7.8.2 Dechra Animal Health Business Overview
  46. 7.8.3 Dechra Animal Health Veterinary Infectious Diseases Therapeutics Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Dechra Animal Health Veterinary Infectious Diseases Therapeutics Product Portfolio
  48. 7.8.5 Dechra Animal Health Recent Developments
  49. 7.9 Ceva Sante Animale
  50. 7.9.1 Ceva Sante Animale Company Information
  51. 7.9.2 Ceva Sante Animale Business Overview
  52. 7.9.3 Ceva Sante Animale Veterinary Infectious Diseases Therapeutics Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Ceva Sante Animale Veterinary Infectious Diseases Therapeutics Product Portfolio
  54. 7.9.5 Ceva Sante Animale Recent Developments
  55. 7.10 Boehringer Ingelheim Vetmedica
  56. 7.10.1 Boehringer Ingelheim Vetmedica Company Information
  57. 7.10.2 Boehringer Ingelheim Vetmedica Business Overview
  58. 7.10.3 Boehringer Ingelheim Vetmedica Veterinary Infectious Diseases Therapeutics Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Boehringer Ingelheim Vetmedica Veterinary Infectious Diseases Therapeutics Product Portfolio
  60. 7.10.5 Boehringer Ingelheim Vetmedica Recent Developments
8 North America
  1. 8.1 North America Veterinary Infectious Diseases Therapeutics Market Size by Type
  2. 8.1.1 North America Veterinary Infectious Diseases Therapeutics Revenue by Type (2021-2032)
  3. 8.1.2 North America Veterinary Infectious Diseases Therapeutics Sales by Type (2021-2032)
  4. 8.1.3 North America Veterinary Infectious Diseases Therapeutics Price by Type (2021-2032)
  5. 8.2 North America Veterinary Infectious Diseases Therapeutics Market Size by Application
  6. 8.2.1 North America Veterinary Infectious Diseases Therapeutics Revenue by Application (2021-2032)
  7. 8.2.2 North America Veterinary Infectious Diseases Therapeutics Sales by Application (2021-2032)
  8. 8.2.3 North America Veterinary Infectious Diseases Therapeutics Price by Application (2021-2032)
  9. 8.3 North America Veterinary Infectious Diseases Therapeutics Market Size by Country
  10. 8.3.1 North America Veterinary Infectious Diseases Therapeutics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Veterinary Infectious Diseases Therapeutics Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Veterinary Infectious Diseases Therapeutics Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Veterinary Infectious Diseases Therapeutics Market Size by Type
  2. 9.1.1 Europe Veterinary Infectious Diseases Therapeutics Revenue by Type (2021-2032)
  3. 9.1.2 Europe Veterinary Infectious Diseases Therapeutics Sales by Type (2021-2032)
  4. 9.1.3 Europe Veterinary Infectious Diseases Therapeutics Price by Type (2021-2032)
  5. 9.2 Europe Veterinary Infectious Diseases Therapeutics Market Size by Application
  6. 9.2.1 Europe Veterinary Infectious Diseases Therapeutics Revenue by Application (2021-2032)
  7. 9.2.2 Europe Veterinary Infectious Diseases Therapeutics Sales by Application (2021-2032)
  8. 9.2.3 Europe Veterinary Infectious Diseases Therapeutics Price by Application (2021-2032)
  9. 9.3 Europe Veterinary Infectious Diseases Therapeutics Market Size by Country
  10. 9.3.1 Europe Veterinary Infectious Diseases Therapeutics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Veterinary Infectious Diseases Therapeutics Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Veterinary Infectious Diseases Therapeutics Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Veterinary Infectious Diseases Therapeutics Market Size by Type
  2. 10.1.1 China Veterinary Infectious Diseases Therapeutics Revenue by Type (2021-2032)
  3. 10.1.2 China Veterinary Infectious Diseases Therapeutics Sales by Type (2021-2032)
  4. 10.1.3 China Veterinary Infectious Diseases Therapeutics Price by Type (2021-2032)
  5. 10.2 China Veterinary Infectious Diseases Therapeutics Market Size by Application
  6. 10.2.1 China Veterinary Infectious Diseases Therapeutics Revenue by Application (2021-2032)
  7. 10.2.2 China Veterinary Infectious Diseases Therapeutics Sales by Application (2021-2032)
  8. 10.2.3 China Veterinary Infectious Diseases Therapeutics Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Veterinary Infectious Diseases Therapeutics Market Size by Type
  2. 11.1.1 Asia Veterinary Infectious Diseases Therapeutics Revenue by Type (2021-2032)
  3. 11.1.2 Asia Veterinary Infectious Diseases Therapeutics Sales by Type (2021-2032)
  4. 11.1.3 Asia Veterinary Infectious Diseases Therapeutics Price by Type (2021-2032)
  5. 11.2 Asia Veterinary Infectious Diseases Therapeutics Market Size by Application
  6. 11.2.1 Asia Veterinary Infectious Diseases Therapeutics Revenue by Application (2021-2032)
  7. 11.2.2 Asia Veterinary Infectious Diseases Therapeutics Sales by Application (2021-2032)
  8. 11.2.3 Asia Veterinary Infectious Diseases Therapeutics Price by Application (2021-2032)
  9. 11.3 Asia Veterinary Infectious Diseases Therapeutics Market Size by Country
  10. 11.3.1 Asia Veterinary Infectious Diseases Therapeutics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Veterinary Infectious Diseases Therapeutics Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Veterinary Infectious Diseases Therapeutics Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Veterinary Infectious Diseases Therapeutics Market Size by Type
  2. 12.1.1 SAMEA Veterinary Infectious Diseases Therapeutics Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Veterinary Infectious Diseases Therapeutics Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Veterinary Infectious Diseases Therapeutics Price by Type (2021-2032)
  5. 12.2 SAMEA Veterinary Infectious Diseases Therapeutics Market Size by Application
  6. 12.2.1 SAMEA Veterinary Infectious Diseases Therapeutics Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Veterinary Infectious Diseases Therapeutics Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Veterinary Infectious Diseases Therapeutics Price by Application (2021-2032)
  9. 12.3 SAMEA Veterinary Infectious Diseases Therapeutics Market Size by Country
  10. 12.3.1 SAMEA Veterinary Infectious Diseases Therapeutics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Veterinary Infectious Diseases Therapeutics Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Veterinary Infectious Diseases Therapeutics Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Veterinary Infectious Diseases Therapeutics Value Chain Analysis
  2. 13.1.1 Veterinary Infectious Diseases Therapeutics Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Veterinary Infectious Diseases Therapeutics Production Mode & Process
  6. 13.2 Veterinary Infectious Diseases Therapeutics Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Veterinary Infectious Diseases Therapeutics Distributors
  9. 13.2.3 Veterinary Infectious Diseases Therapeutics Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst